The overarching goal of this study is to examine the efficacy of a brief video intervention in reducing stigma and fear, and improving help-seeking behavior, among health care providers (N=1,200), with pre- post- and follow-up assessments (at day 14 and day 30). Participants will be recruited via Amazon Turk and randomly assigned to either a) a video-based intervention (day 1 and a "booster intervention" of the same content on day 14 of the study) featuring the personal story of a health care provider during COVID-19 pandemic, his/her struggles and barriers to care, (b) video-based intervention (day 1 only), and a written description of the same story on day 14 (c) no-intervention control arm (questionnaires only). The invetsigators aim to (1) determine whether video-based intervention reduce stigma and fear, and increase help-seeking behavior in relation to COVID-19 among health care providers, and (2) compare high-risk areas (e.g., NY) to low-risk areas (e.g., Montana) on intervention outcomes, and (3) test whether symptoms of depression, anxiety, PTSD and Moral Injury (measured by the Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder (GAD-7), the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) and the Moral Injury Events Scale (MIES)) would change over time.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Help-seeking Behavior
Timeframe: Assessed at baseline and post-intervention (both day 1), first follow-up (day 14), and second follow-up (day 30)
Generalized Anxiety Disorder-7 (GAD-7)
Timeframe: Assessed at baseline, 14-day follow-up, and 30-day follow-up
Patient Health Questionnaire-9 (PHQ-9)
Timeframe: Assessed at baseline, 14-day follow-up, and 30-day follow-up
Primary Care Posttraumatic Stress Disorder (PC-PTSD) Screen
Timeframe: Assessed at baseline, 14-day follow-up, and 30-day follow-up
Moral Injury Events Scale (MIES)
Timeframe: Assessed at baseline, 14-day follow-up, and 30-day follow-up